The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Between 2000-2007, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) delivered more than 1.9 billion treatments to nearly 600 million individuals via annual mass drug administration (MDA) of anti-filarial drugs (albendazole, ivermectin, diethylcarbamazine) to all at-risk for 4-6 years....

Full description

Bibliographic Details
Main Authors: Brian K Chu, Pamela J Hooper, Mark H Bradley, Deborah A McFarland, Eric A Ottesen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-06-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC2879371?pdf=render

Internet

http://europepmc.org/articles/PMC2879371?pdf=render

Similar Items